First Financial Corp’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.31K | Hold |
42
| – | – | ﹤0.01% | 276 |
|
|
2026
Q1 | $5.85K | Sell |
42
-35
| -45% | -$4.9K | ﹤0.01% | 275 |
|
|
2025
Q4 | $9.45K | Hold |
77
| – | – | ﹤0.01% | 266 |
|
|
2025
Q3 | $8.55K | Hold |
77
| – | – | ﹤0.01% | 275 |
|
|
2025
Q2 | $8.54K | Sell |
77
-662
| -90% | -$70.5K | ﹤0.01% | 270 |
|
|
2025
Q1 | $82.8K | Hold |
739
| – | – | 0.04% | 174 |
|
|
2024
Q4 | $68.3K | Buy |
+739
| New | +$66.5K | 0.03% | 196 |
|
|
2024
Q3 | – | Sell |
-655
| Closed | -$44.9K | – | 450 |
|
|
2024
Q2 | $44.9K | Hold |
655
| – | – | 0.02% | 213 |
|
|
2024
Q1 | $48K | Hold |
655
| – | – | 0.02% | 219 |
|
|
2023
Q4 | $53.1K | Hold |
655
| – | – | 0.03% | 231 |
|
|
2023
Q3 | $49.1K | Buy |
+655
| New | +$50.4K | 0.03% | 232 |
|
|
2020
Q4 | – | Sell |
-250
| Closed | -$16K | – | 366 |
|
|
2020
Q3 | $16K | Buy |
+250
| New | +$17.3K | 0.01% | 270 |
|
|
2020
Q1 | – | Sell |
-541
| Closed | -$35K | – | 346 |
|
|
2019
Q4 | $35K | Hold |
541
| – | – | 0.03% | 230 |
|
|
2019
Q3 | $34K | Buy |
541
+401
| +286% | +$26.2K | 0.03% | 227 |
|
|
2019
Q2 | $9K | Hold |
140
| – | – | 0.01% | 282 |
|
|
2019
Q1 | $9K | Hold |
140
| – | – | 0.01% | 290 |
|
|
2018
Q4 | $9K | Hold |
140
| – | – | 0.01% | 287 |
|
|
2018
Q3 | $11K | Hold |
140
| – | – | 0.01% | 295 |
|
|
2018
Q2 | $10K | Hold |
140
| – | – | 0.01% | 301 |
|
|
2018
Q1 | $11K | Sell |
140
-45
| -24% | -$3.58K | 0.01% | 307 |
|
|
2017
Q4 | $13K | Sell |
185
-193
| -51% | -$14.7K | 0.01% | 316 |
|
|
2017
Q3 | $31K | Hold |
378
| – | – | 0.02% | 276 |
|
|
2017
Q2 | $27K | Sell |
378
-250
| -40% | -$16.6K | 0.02% | 287 |
|
|
2017
Q1 | $43K | Sell |
628
-163
| -21% | -$11.5K | 0.03% | 235 |
|
|
2016
Q4 | $56K | Sell |
791
-710
| -47% | -$52.8K | 0.03% | 199 |
|
|
2016
Q3 | $119K | Sell |
1,501
-961
| -39% | -$78.1K | 0.07% | 147 |
|
|
2016
Q2 | $205K | Sell |
2,462
-4,960
| -67% | -$440K | 0.12% | 119 |
|
|
2016
Q1 | $682K | Buy |
7,422
+225
| +3% | +$20.3K | 0.36% | 73 |
|
|
2015
Q4 | $728K | Sell |
7,197
-850
| -11% | -$88.4K | 0.39% | 69 |
|
|
2015
Q3 | $790K | Sell |
8,047
-785
| -9% | -$87.2K | 0.44% | 61 |
|
|
2015
Q2 | $1.03M | Buy |
8,832
+810
| +10% | +$88.5K | 0.52% | 50 |
|
|
2015
Q1 | $787K | Buy |
8,022
+15
| +0.2% | +$1.52K | 0.4% | 63 |
|
|
2014
Q4 | $755K | Buy |
8,007
+2,095
| +35% | +$217K | 0.38% | 67 |
|
|
2014
Q3 | $630K | Sell |
5,912
-20
| -0.3% | -$1.96K | 0.31% | 79 |
|
|
2014
Q2 | $492K | Buy |
5,932
+2,865
| +93% | +$223K | 0.24% | 98 |
|
|
2014
Q1 | $217K | Buy |
3,067
+385
| +14% | +$30.2K | 0.1% | 151 |
|
|
2013
Q4 | $201K | Buy |
2,682
+672
| +33% | +$46.8K | 0.09% | 155 |
|
|
2013
Q3 | $127K | Sell |
2,010
-162
| -7% | -$9.68K | 0.06% | 186 |
|
|
2013
Q2 | $111K | Buy |
+2,172
| New | +$113K | 0.06% | 196 |
|
Other funds holding GILD
LMFP
CIM
ATO
CGH
First Financial Corp's GILD Position: Q2 2026 in Review
First Financial Corp held its Gilead Sciences (GILD) position steady in Q2 2026 at 42 shares worth $5.31K. The position accounts for ﹤0.01% of the portfolio, ranked #276.
First Financial Corp first reported a position in GILD in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.03M in Q2 2015. 610 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- First Financial Corp held 42 shares of Gilead Sciences worth $5.31K as of Q2 2026.
- First Financial Corp left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up ﹤0.01% of First Financial Corp's portfolio in Q2 2026, its #276 holding.
- First Financial Corp first reported a position in Gilead Sciences in Q2 2013 and has held it in 39 quarters since.
- First Financial Corp's Gilead Sciences position peaked at $1.03M in Q2 2015.
- 610 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on First Financial Corp's 13F filing for Q2 2026, filed 7 Jul 2026.